Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) announced that TH-302 will be featured among several presentations by academic and industry experts at a symposium entitled Therapeutic and Diagnostic Modalities Targeting Hypoxia in Cancer, hosted by the New York Academy of Sciences on Wednesday, March 14, in New York City. Threshold Pharmaceuticals is also a sponsor of the event.